Iluvien medidur: Phase I/II started

pSivida said investigators began a U.S. Phase I/II trial to evaluate Medidur in posterior uveitis patients. Alimera Sciences Inc. (NASDAQ:ALIM, Alpharetta, Ga.) has rights to Medidur from pSivida for...